The National Retail Federation released a survey last Tuesday that stores across the U.S. lost an “unprecedented” $112.1 billion to theft in 2022.
Category: TRENDS IN THE COVID WAR – Oct 3 2023
Post
MERCK’S $6B COVID-19 ANTIVIRAL DRUG MAY CONTRIBUTE TO VIRUS’S MUTATION, SCIENTISTS SAY
Molnupiravir, Merck’s COVID-19 antiviral drug that earned the company $6 billion in sales from 2021 to 2022, may be contributing to the disease’s mutation since the virus can survive the treatment, scientists said.
Post
FDA UPDATES WARNING LABEL FOR OZEMPIC DUE TO LIFE-THREATENING INTESTINAL BLOCKAGE RISK
The U.S. Food and Drug Administration announced last week that it will update the warning label on Ozempic—the diabetes drug popular for weight loss—due to the risk of intestinal blockage while on the drug.